Abstract.
Patient education, identification of possible triggers of syncope and reassurance are a central feature of the management of patients with reflex syncope. Patients should be advised as to the importance of adequate hydration and taught physical countermaneuvers to enhance cardiac venous return. These maneuvers are sufficient for most patients, however, for a small number of patients who continue to have recurrent syncopal events, pharmacological intervention may be considered. Volume expansion can be enhanced with salt and fludrocortisone. Agents from diverse pharmacological classes have been used to attenuate the reflex response, enhance vasoconstriction and attenuate vagal outflow. Alpha adrenoreceptor agonists, anticholinergic agents, theophylline, beta adrenoreceptor antagonists, serotonin reuptake inhibitors and disopyramide are the most widely studied. None of these agents has shown a consistent therapeutic benefit in clinical trials.
Similar content being viewed by others
References
Alegria JR, Gersh BJ, Scott CG, Hodge DO, Hammill SC, Shen WK (2003) Comparison of frequency of recurrent syncope after beta-blocker therapy versus conservative management for patients with vasovagal syncope. Am J Cardiol 92:82–84
Benditt DG, Benson DW Jr, Kreitt J, Dunnigan A, Pritzker MR, Crouse L, Scheinman MM (1983) Electrophysiologic effects of theophylline in young patients with recurrent symptomatic bradyarrhythmias. Am J Cardiol 52:1223–1229
Brignole M, Alboni P, Benditt D, Bergfeldt L, Blanc JJ, Bloch Thomsen PE, van Dijk JG, Fitzpatrick A, Hohnloser S, Janousek J, Kapoor W, Kenny RA, Kulakowski P, Moya A, Raviele A, Sutton R, Theodorakis G, Wieling W (2001) Guidelines on management (diagnosis and treatment) of syncope. Eur Heart J 22:1256–1306
Brignole M, Gaggioli G, Menozzi C, Gianfranchi L, Bartoletti A, Bottoni N, Lolli G, Oddone D, Del Rosso A, Pellinghelli G (1997) Adenosine-induced atrioventricular block in patients with unexplained syncope: the diagnostic value of ATP testing. Circulation 96:3921–3927
Di Girolamo E, Di Iorio C, Sabatini P, Leonzio L, Barbone C, Barsotti A (1999) Effects of paroxetine hydrochloride, a selective serotonin reuptake inhibitor, on refractory vasovagal syncope: a randomized, double-blind, placebo-controlled study. J Am Coll Cardiol 33:1227–1230
Dietz NM, Engelke KA, Samuel TT, Fix RT, Joyner MJ (1997) Evidence for nitric oxide-mediated sympathetic forearm vasodilatation in humans. J Physiol 498:531–540
Dietz NM, Halliwill JR, Spielmann JM, Lawler LA, Papouchado BG, Eickhoff TJ, Joyner MJ (1997) Sympathetic withdrawal and forearm vasodilation during vasovagal syncope in humans. J Appl Physiol 82:1785–1793
Ehringer H (1971) Study of human peripheral hemodynamics after i. v. infusion of a small dosage of dl-1-(2’,5’-dimethoxyphenyl)-2-glycinamidoethanol-(1) hydrochloride (= st 1085). Int Z Klin Pharmakol Ther Toxikol 4:415–420
El-Sayed H, Hainsworth R (1995) Relationship between plasma volume, carotid baroreceptor sensitivity and orthostatic tolerance. Clinical Science 88:463–470
El-Sayed H, Hainsworth R (1996) Salt supplement increases plasma volume and orthostatic tolerance in patients with unexplained syncope. Heart 75:134–140
Flevari P, Livanis EG, Theodorakis GN, Zarvalis E, Mesiskli T, Kremastinos DT (2002) Vasovagal syncope: a prospective, randomized, crossover evaluation of the effect of propranolol, nadolol and placebo on syncope recurrence and patients’ well-being. J Am Coll Cardiol 40:499–504
Jacob G, Robertson D, Mosqueda Garcia R, Ertl AC, Robertson RM, Biaggioni I (1997) Hypovolemia in syncope and orthostatic intolerance role of the renin-angiotensin system. Am J Med 103:128–133
Kaufmann H, Berman J, Oribe E, Oliver J (1993) Possible increase in the synthesis of endothelial derived relaxing factor (EDRF) during vasovagal syncope. Clin Auton Res 3:69 (Abs)
Kaufmann H, Brannan T, Krakoff L, Yahr MD, Mandeli J (1988) Treatment of orthostatic hypotension due to autonomic failure with a peripheral alpha-adrenergic agonist (midodrine). Neurology 38:951–956
Kaufmann H, Saadia D, Voustianiouk A (2002) Midodrine in neurally mediated syncope: a double-blind, randomized, crossover study. Ann Neurol 52:342–345
Lee TM, Su SF, Chen MF, Liau CS, Lee YT (1996) Usefulness of transdermal scopolamine for vasovagal syncope. Am J Cardiol 78:480–482
Lewis T (1932) Lecture on vasovagal syncope and the carotid sinus mechanism. Br Med J 1:873–876
Low PA, Gilden JL, Freeman R, Sheng KN, McElligott MA (1997) Efficacy of midodrine vs placebo in neurogenic orthostatic hypotension. A randomized, double-blind multicenter study. Midodrine Study Group. JAMA 277:1046–1051
Madrid AH, Ortega J, Rebollo JG, Manzano JG, Segovia JG, Sanchez A, Pena G, Moro C (2001) Lack of efficacy of atenolol for the prevention of neurally mediated syncope in a highly symptomatic population: a prospective, double-blind, randomized and placebo-controlled study. J Am Coll Cardiol 37:554–559
Mahanonda N, Bhuripanyo K, Kangkagate C, Wansanit K, Kulchot B, Nademanee K, Chaithiraphan S (1995) Randomized double-blind, placebo-controlled trial of oral atenolol in patients with unexplained syncope and positive upright tilt table test results. Am Heart J 130:1250–1253
Milstein S, Buetikofer J, Lesser J, Goldenberg IF, Benditt DG, Gornick C, Reyes WJ (1989) Cardiac asystole: a manifestation of neurally mediated hypotension-bradycardia (see comments). J Am Coll Cardiol 14:1626–1632
Morillo C, Leitch J, Yee R, Klein G (1993) A placebo-controlled trial of intravenous and oral disopyramide for prevention of neurally mediated syncope induced by head-up tilt. J Am Coll Cardiol 22:1843–1848
Morillo CA, Klein GJ, Gersh BJ (1996) Can serial tilt testing be used to evaluate therapy in neurally mediated syncope? Am J Cardiol 77:521–523
Nelson SD, Stanley M, Love CJ, Coyne KS, Schaal SF (1991) The autonomic and hemodynamic effects of oral theophylline in patients with vasodepressor syncope. Arch Intern Med 151:2425–2429
Oribe E, Kaufmann H, Winters S, Gomes J (1992) Fludrocortisone versus Beta-Adrenergic Blockers in the treatment of vasovagal syncope. Neurology 42:213
Pollick C (1995) Effects of disopyramide on diastolic function in hypertrophic cardiomyopathy. Am J Cardiol 75:652
Ramsdell CD, Mullen TJ, Sundby GH, Rostoft S, Sheynberg N, Aljuri N, Maa M, Mukkamala R, Sherman D, Toska K, Yelle J, Bloomfield D, Williams GH, Cohen RJ (2001) Midodrine prevents orthostatic intolerance associated with simulated spaceflight. J Appl Physiol 90:2245–2248
Raviele A, Brignole M, Sutton R, Alboni P, Giani P, Menozzi C, Moya A (1999) Effect of etilefrine in preventing syncopal recurrence in patients with vasovagal syncope: a double-blind, randomized, placebo-controlled trial. The Vasovagal Syncope International Study. Circulation 99:1452–1457
Rowe PC, Calkins H, DeBusk K, McKenzie R, Anand R, Sharma G, Cuccherini BA, Soto N, Hohman P, Snader S, Lucas KE, Wolff M, Straus SE (2001) Fludrocortisone acetate to treat neurally mediated hypotension in chronic fatigue syndrome: a randomized controlled trial. JAMA 285:52–59
Scott WA, Pongiglione G, Bromberg BI, Schaffer MS, Deal BJ, Fish FA, Dick M (1995) Randomized comparison of atenolol and fludrocortisone acetate in the treatment of pediatric neurally mediated syncope. Am J Cardiol 76:400–402
Sheldon R, Rose S, Flanagan P, Koshman ML, Killam S (1996) Effect of beta blockers on the time to first syncope recurrence in patients after a positive isoproterenol tilt table test. Am J Cardiol 78:536–539
Sinkovec M, Grad A, Rakovec P (2001) Role of endogenous adenosine in vasovagal syncope. Clin Auton Res 11:155–161
Takata TS, Wasmund SL, Smith ML, Li JM, Joglar JA, Banks K, Kowal RC, Page RL, Hamdan MH (2002) Serotonin reuptake inhibitor (Paxil) does not prevent the vasovagal reaction associated with carotid sinus massage and/or lower body negative pressure in healthy volunteers. Circulation 106:1500–1504
Ward CR, Gray JC, Gilroy JJ, Kenny RA (1998) Midodrine: a role in the management of neurocardiogenic syncope. Heart 79:45–49
Wieling W, Van Lieshout JJ, Hainsworth R (2002) Extracellular fluid volume expansion in patients with posturally related syncope. Clin Auton Res 12:242–249
Wright RA, Kaufmann HC, Perera R, Opfer-Gehrking TL, McElligott MA, Sheng KN, Low PA (1998) A double-blind, dose-response study of midodrine in neurogenic orthostatic hypotension. Neurology 51:120–124
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Kaufmann, H., Freeman, R. Pharmacological treatment of reflex syncope. Clin Auton Res 14 (Suppl 1), i71–i75 (2004). https://doi.org/10.1007/s10286-004-1010-4
Issue Date:
DOI: https://doi.org/10.1007/s10286-004-1010-4